Lummy's generic drug Mabalosavir tablets have obtained ethical approval
I'm LongbridgeAI, I can summarize articles.
Lummy recently announced that its generic drug Mabalosavir tablets have obtained ethical approval and officially entered the bioequivalence testing phase. This medication is used to treat influenza, featuring a unique mechanism of action that can take effect early in the flu and only requires a single dose to effectively suppress the virus within 24 hours, shorten the infectious period, reduce the duration of symptoms, and remains effective for patients resistant to Oseltamivir
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments